...
首页> 外文期刊>Journal of Hainan Medical University >Effect of danhong injection combined with nadroparin calcium on serum CyS-C, CRP, IL-6, vWF, ET and VEGF in patients with acute coronary syndrome
【24h】

Effect of danhong injection combined with nadroparin calcium on serum CyS-C, CRP, IL-6, vWF, ET and VEGF in patients with acute coronary syndrome

机译:丹红注射液联合萘达帕林钙对急性冠脉综合征患者血清CyS-C,CRP,IL-6,vWF,ET和VEGF的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: To study the effect of danhong injection combined with nadroparin calcium onserum CyS-C, CRP, IL-6, vWF, ET and VEGF in patients with acute coronary syndrome.Methods: A total of 80 patients with acute coronary syndrome in our hospital from July2014 to July 2017 were enrolled in this study. The subjects were divided into the controlgroup (n=40) and the treatment group (n=40) randomly. The control group was treated withxuesaitong injection combined with nadroparin calcium; the treatment group was treatedwith danhong injection combined with nadroparin calcium. The two groups were treated for2 weeks. The serum CyS-C, CRP, IL-6, vWF, ET and VEGF levels of the two groups beforeand after treatment were compared. Results: There were no significantly differences of theserum CyS-C, CRP, IL-6, vWF, ET and VEGF levels of the two groups before treatment. Theserum CyS-C, CRP, IL-6, vWF, ET and VEGF levels of the two groups after treatment weresignificantly lower than before treatment, and that of the treatment group were significantlybetter than that of the control group. Conclusion: Danhong injection combined withnadroparin calcium can significantly reduce the serum CyS-C, CRP, IL-6, vWF, ET and VEGFlevels of patients with acute coronary syndrome, and it was worthy clinical application.
机译:目的:探讨丹红注射液联合萘达普林钙对急性冠脉综合征患者血清CyS-C,CRP,IL-6,vWF,ET和VEGF的影响。方法:本院共80例急性冠脉综合征患者。从2014年7月至2017年7月参加了这项研究。将受试者随机分为对照组(n = 40)和治疗组(n = 40)。对照组采用血塞通注射液联合萘哌林钙治疗。治疗组采用丹红注射液联合萘哌林钙治疗。两组均治疗2周。比较两组治疗前后的血清CyS-C,CRP,IL-6,vWF,ET和VEGF水平。结果:治疗前两组血清theseCyS-C,CRP,IL-6,vWF,ET和VEGF水平无明显差异。两组治疗后的草CyS-C,CRP,IL-6,vWF,ET和VEGF水平明显低于治疗前,治疗组明显优于对照组。结论:丹红注射液联合萘哌林钙可显着降低急性冠脉综合征患者的血清CyS-C,CRP,IL-6,vWF,ET和VEGF水平,值得临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号